|
|
RTOG Biospecimen Repository
|
5U24CA114734-08
|
$977,658
|
$97,766
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
Angiogenin-induced RNA cleavage in cancer
|
1R01CA168872-01A1
|
$356,063
|
$178,032
|
ANDERSON, PAUL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Genetic and Biochemical Studies of the KSHV LANA Gene
|
5R01CA082036-14
|
$363,204
|
$363,204
|
Kaye, Kenneth
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Case Comprehensive Cancer Center Support Grant
|
2P30CA043703-23
|
$4,740,480
|
$47,405
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-23S2
|
$37,026
|
$370
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
The Role of JAB1 in osteosarcoma pathogenesis
|
1R03CA175874-01
|
$79,063
|
$79,063
|
Zhou, Guang
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
SBIR Phase II Topic 307: Monitoring Anticancer Immune Response Non-Invasively wit
|
N44CO130063-000
|
$1,499,971
|
$749,986
|
YAGHOUBI, SHAHRIAR
|
CELLSIGHT TECHNOLOGIES, INC.
|
|
|
Bone and Soft Tissue Tumor Etiology: Role and Function of TRE17/USP6
|
1R01CA168452-01A1
|
$266,216
|
$133,108
|
Chou, Margaret
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
Pathogenic mechanisms of alveolar rhabdomyosarcoma
|
1R21CA178601-01
|
$218,588
|
$218,588
|
Chou, Margaret
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
Autophagy and apoptosis in the response of c-KIT cancers to targeted therapy
|
5K08CA154782-03
|
$143,362
|
$71,681
|
GORDON, PETER
|
CHILDREN'S HOSPITAL CORPORATION
|
|
|
Pneumatic Robot for MRI-Guided Pediatrics Long Bone Biopsy
|
1R01CA172244-01A1
|
$583,690
|
$583,690
|
CLEARY, KEVIN
|
CHILDREN'S RESEARCH INSTITUTE
|
|
|
Targeting Tumor Cell Iron Addiction to Achieve Tumor-Selective Cell Death
|
5K99CA166517-02
|
$124,994
|
$31,249
|
Dixon, Scott
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
|
|
Cancer Center Support Grant
|
3P30CA013696-39S3
|
$3,546,194
|
$70,924
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
3P30CA013696-39S4
|
$75,000
|
$1,500
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
3P30CA013696-39S5
|
$125,000
|
$2,500
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
3P30CA013696-39S6
|
$49,718
|
$994
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Functionizing the epigenome in Ewing sarcoma
|
7R21CA166805-03
|
$163,560
|
$163,560
|
KUNG, ANDREW
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Columbia-South Africa Training Program for Research on HIV-associated Malignanci
|
3D43CA153715-03S1
|
$233,333
|
$79,333
|
NEUGUT, ALFRED
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Quantitative Volume and Density Response Assessment: Sarcoma and HCC as a Model
|
5U01CA140207-03
|
$536,959
|
$268,480
|
Schwartz, Lawrence
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Osteosarcoma in Dogs as a Model for the Development of Drugs to Treat Micro-metas
|
1R43CA167887-01A1
|
$266,172
|
$266,172
|
Brewer, George
|
CYPRIS, LLC
|
|
|
Cancer Center Support Grant
|
3P30CA006516-48S1
|
$114,538
|
$1,145
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
|
Cancer Center Support Grant
|
3P30CA006516-48S3
|
$12,500
|
$125
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
|
Cancer Center Support Grant
|
3P30CA006516-48S4
|
$50,000
|
$500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
|
Cancer Center Support Grant
|
5P30CA006516-48
|
$10,435,722
|
$104,357
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
|
SPORE: DF/HCC SPORE in GASTROINTESTINAL CANCER
|
2P50CA127003-06A1
|
$2,150,500
|
$365,585
|
FUCHS, CHARLES
|
DANA-FARBER CANCER INST
|
|
|
Functionizing the epigenome in Ewing sarcoma
|
5R21CA166805-02
|
|
$0
|
KUNG, ANDREW
|
DANA-FARBER CANCER INST
|
|
|
Exploiting mouse models of pediatric cancers and epigenetics for therapy
|
5U01CA105423-10
|
$728,812
|
$481,016
|
ORKIN, STUART
|
DANA-FARBER CANCER INST
|
|
|
Cancer Center Support Grant
|
3P30CA023108-35S1
|
$12,500
|
$125
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
|
Cancer Center Support Grant
|
3P30CA023108-35S2
|
$50,000
|
$500
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
|
Cancer Center Support Grant
|
5P30CA023108-35
|
$2,922,577
|
$29,226
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
|
Immune surveillance in murine gammaherpesvirus infection
|
5R01CA103642-10
|
$259,585
|
$88,259
|
Usherwood, Edward
|
DARTMOUTH COLLEGE
|
|
|
Duke Comp Cancer Inst. Core Support Grant
|
3P30CA014236-39S1
|
$18,744
|
$562
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
|
Duke Comp Cancer Inst. Core Support Grant
|
5P30CA014236-39
|
$5,351,774
|
$160,553
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
|
Radiation Therapy: Dissecting the Role of Stromal Cells in Tumor Control
|
1R01CA169220-01A1
|
$415,105
|
$415,105
|
KIRSCH, DAVID
|
DUKE UNIVERSITY
|
|
|
Molecular Modeling of Pediatric Skeletal Muscle Tumors
|
5R01CA122706-05
|
$265,634
|
$265,634
|
LINARDIC, CORINNE
|
DUKE UNIVERSITY
|
|
|
Defining the cellular target of radiotherapy in primary mouse models of cancer
|
1F30CA177220-01
|
$39,432
|
$19,716
|
Moding, Everett
|
DUKE UNIVERSITY
|
|
|
Dissecting the roles of HIF-1a and HIF-2a in tumor response to radiation therapy
|
1F30CA180680-01
|
$43,452
|
$43,452
|
Zhang, Minsi
|
DUKE UNIVERSITY
|
|
|
Clinical validation of the SureDx EFT diagnostic test
|
3R41CA156942-01A1S1
|
$145,080
|
$145,080
|
Potikyan, Gary
|
ENTROGEN, INC.
|
|
|
Improved Diagnosis of Kaposi's Sarcoma Herpes Virus Infection
|
5R44CA134172-03
|
$526,885
|
$526,885
|
DONG, STEVEN
|
EPIPHANY BIOSCIENCES, INC.
|
|
|
Impact of HIV and HHV-8 Co-Infection on Antiretroviral Therapy Efficacy in Africa
|
5R01CA138165-04
|
$282,976
|
$282,976
|
CASPER, COREY
|
FRED HUTCHINSON CAN RES CTR
|
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S1
|
$109,383
|
$1,094
|
Corey, Lawrence
|
FRED HUTCHINSON CAN RES CTR
|
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S2
|
$18,750
|
$188
|
Corey, Lawrence
|
FRED HUTCHINSON CAN RES CTR
|
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S3
|
$125,000
|
$1,250
|
Corey, Lawrence
|
FRED HUTCHINSON CAN RES CTR
|
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S4
|
$50,000
|
$500
|
Corey, Lawrence
|
FRED HUTCHINSON CAN RES CTR
|
|
|
Cancer Center Support Grant (Comprehensive)
|
5P30CA015704-39
|
$10,072,717
|
$100,727
|
Corey, Lawrence
|
FRED HUTCHINSON CAN RES CTR
|
|
|
Human Herpesvirus-8 Replication and Kaposi Sarcoma Response to Treatment
|
5K23CA150931-03
|
$142,429
|
$142,429
|
Phipps, Warren
|
FRED HUTCHINSON CAN RES CTR
|
|
|
Adoptive T cell Therapy for Patients with NY-ESO-1 Expressing Sarcomas
|
1K23CA175167-01
|
$171,720
|
$171,720
|
POLLACK, SETH
|
FRED HUTCHINSON CAN RES CTR
|
|
|
In vivo model of hypoxia in Ewing Sarcoma
|
1R03CA178809-01
|
$77,750
|
$77,750
|
KITLINSKA, JOANNA
|
GEORGETOWN UNIVERSITY
|
|
|
Novel Compounds to Inactivate Oncogenic Fusion Proteins
|
5R01CA133662-05
|
$290,421
|
$290,421
|
TORETSKY, JEFFREY
|
GEORGETOWN UNIVERSITY
|
|
|
Georgetown University, Lombardi Cancer Center Support Grant Competitive Renewal
|
3P30CA051008-20S1
|
$43,750
|
$1,313
|
WEINER, LOUIS
|
GEORGETOWN UNIVERSITY
|
|
Total relevant funding to Sarcoma for this search: $59,276,593
|
